The restoration of NID2 expression in cancer cells was shown to have a negative regulatory role in Epidermal Growth Factor Receptor (EGFR) and integrin signaling pathways, suggesting that NID2 elicits in vitro migration/invasion suppression and in vivo metastasis inhibition effects through negative modulation of these two oncogenic pathways [27]. The gene discussed is NID2; the disease is cancer.